Multi-walled carbon nanotubes conjugated to tumor protein enhance the uptake of tumor antigens by human dendritic cells in vitro

Cell Research

Volumn 20, Issue 10, 2010, Pages 1170-1173

  Sun, Zhao ^a   Wang, Wei ^b   Meng, Jie ^b   Chen, Shuchang ^a   Xu, Haiyan ^b   Yang, Xian Da ^b  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^b INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON NANOTUBE; FLUORESCEIN ISOTHIOCYANATE; TUMOR ANTIGEN; TUMOR PROTEIN;

CHEMISTRY; DENDRITIC CELL; HUMAN; IMMUNOLOGY; LETTER; METABOLISM;

ANTIGENS, NEOPLASM; DENDRITIC CELLS; FLUORESCEIN-5-ISOTHIOCYANATE; HUMANS; NANOTUBES, CARBON; NEOPLASM PROTEINS;

EID: 77957597242     PISSN: 10010602     EISSN: 17487838     Source Type: Journal    
DOI: 10.1038/cr.2010.133     Document Type: Letter

References (10)

1. Vermorken JB, Claessen AM, van Tinteren H, et al. Active specifc immunotherapy for stage II and stage III human colon cancer: a randomised trial. Lancet 1999; 353:345-350.
2. Takayama T, Sekine T, Makuuchi M, et al. Adoptive immuno-therapy to lower postsurgical recurrence rates of hepatocellu-lar carcinoma: a randomised trial. Lancet 2000; 356:802-807.
3. Berd D, Sato T, Maguire HC Jr, et al. Immunopharmacologic analysis of an autologous, hapten-modifed human melanoma vaccine. J Clin Oncol 2004; 22:403-415.
4. Yu JS, Liu G, Ying H, et al. Vaccination with tumor lysate-pulsed dendritic cells elicits antigen-specifc, cytotoxic T-cells in patients with malignant glioma. Cancer Res 2004; 64:4973-4979.
5. Rosenberg SA Progress in human tumour immunology and immunotherapy. Nature 2001; 411:380-384.
6. Brossart P Dendritic cells in vaccination therapies of malignant diseases. Transfus Apher Sci 2002; 27:183-186.
7. Bianco A, Kostarelos K, Partidos CD, et al. Biomedical applications of functionalised carbon nanotubes. Chem Commun (Camb) 2005; 5:571-577.
8. Meng J, Meng J, Duan J, et al. Carbon nanotubes conjugated to tumor lysate protein enhance the effcacy of an antitumor immunotherapy. Small 2008; 4:1364-1370.
9. Jarnjak-Jankovic S, Hammerstad H, Saeboe-Larssen S, et al. A full scale comparative study of methods for generation of functional Dendritic cells for use as cancer vaccines. BMC Cancer 2007; 7:119.
10. Haas C, Lulei M, Fournier P, et al. A tumor vaccine containing anti-CD3 and anti-CD28 bispecific antibodies triggers strong and durable antitumor activity in human lymphocytes. Int J Cancer 2006; 118:658-667.